LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER · 20 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | HALO | HALOZYME THERAPEUTICS, INC. | Tax withholding | 3,608 | $70.64 | $254,869.12 | filing |
| 2026-02-23 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 6,688 | $0.00 | $0.00 | filing |
| 2026-02-20 | HALO | HALOZYME THERAPEUTICS, INC. | Tax withholding | 2,876 | $70.98 | $204,138.48 | filing |
| 2026-02-20 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 5,332 | $0.00 | $0.00 | filing |
| 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Tax withholding | 7,273 | $79.44 | $577,767.12 | filing |
| 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Tax withholding | 2,874 | $79.44 | $228,310.56 | filing |
| 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Tax withholding | 2,747 | $79.44 | $218,221.68 | filing |
| 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 5,329 | $0.00 | $0.00 | filing |
| 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 13,351 | $0.00 | $0.00 | filing |
| 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 5,093 | $0.00 | $0.00 | filing |
| 2025-09-22 | HALO | HALOZYME THERAPEUTICS, INC. | Sale | 1,913 | $77.83 | $148,883.05 | filing |
| 2025-09-22 | HALO | HALOZYME THERAPEUTICS, INC. | Sale | 314 | $78.67 | $24,701.44 | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Sale | 13,240 | $75.93 | $1.0M | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Sale | 13,240 | $75.93 | $1.0M | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Sale | 6,760 | $75.29 | $508,967.16 | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Sale | 6,760 | $75.29 | $508,967.16 | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 11,271 | $12.07 | $136,040.97 | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 11,271 | $12.07 | $136,040.97 | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 1,135 | $12.49 | $14,176.15 | filing |
| 2025-09-10 | HALO | HALOZYME THERAPEUTICS, INC. | Option exercise | 1,135 | $12.49 | $14,176.15 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.